---
title: "Lakefront Biotherapeutics Reports Half-Year 2026 Financial Results and Provides Business Update"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295445728.md"
description: "The acquisition of Ouro Medicines by Gilead Sciences has been successfully concluded. This collaboration aims to further develop a groundbreaking T-cell engager, potentially the first and most effective of its kind."
datetime: "2026-08-10T20:02:58.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295445728.md)
  - [en](https://longbridge.com/en/news/295445728.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295445728.md)
generator: "portal-rs"
---

# Lakefront Biotherapeutics Reports Half-Year 2026 Financial Results and Provides Business Update

The acquisition of Ouro Medicines by Gilead Sciences has been successfully concluded. This collaboration aims to further develop a groundbreaking T-cell engager, potentially the first and most effective of its kind.

### Related Stocks

- [LKFT.US](https://longbridge.com/en/quote/LKFT.US.md)
- [GILD.US](https://longbridge.com/en/quote/GILD.US.md)
- [GIS.DE](https://longbridge.com/en/quote/GIS.DE.md)

## Related News & Research

- [GSA Capital Partners LLP Takes Position in Gilead Sciences, Inc. $GILD](https://longbridge.com/en/news/296193567.md)
- [Grandfield & Dodd LLC Makes New Investment in Gilead Sciences, Inc. $GILD](https://longbridge.com/en/news/296196164.md)
- [05:13 ETKeymed Biosciences Announces 2026 H1 Results and Business Updates](https://longbridge.com/en/news/296594656.md)
- [Confluence Wealth Services Inc. Acquires 7,986 Shares of Gilead Sciences, Inc. $GILD](https://longbridge.com/en/news/295901632.md)
- [ABN Amro Investment Solutions Has $32.39 Million Stock Holdings in Gilead Sciences, Inc. $GILD](https://longbridge.com/en/news/295894826.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**